Company Filing History:
Years Active: 2008-2021
Title: Juergen Distler: Innovator in Cellular Proliferative Disorders
Introduction
Juergen Distler is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of cellular biology, particularly in the analysis of proliferative disorders. With a total of 12 patents to his name, Distler's work has the potential to greatly enhance diagnostic and treatment methods for various diseases.
Latest Patents
One of Juergen Distler's latest patents focuses on methods and nucleic acids for the analysis of cellular proliferative disorders. This invention provides innovative methods, nucleic acids, and kits for detecting and distinguishing between liver cell proliferative disorders and colorectal cell proliferative disorders. The invention discloses genomic sequences whose methylation patterns are useful for improved detection and differentiation of these disorders, thereby enabling better diagnosis and treatment for patients.
Career Highlights
Juergen Distler is currently associated with Epigenomics AG, a company that specializes in the development of innovative diagnostic solutions. His work at Epigenomics AG has been instrumental in advancing the understanding of cellular proliferative disorders and their implications for patient care.
Collaborations
Throughout his career, Juergen Distler has collaborated with notable colleagues, including Fabian Model and Andrew Z Sledziewski. These collaborations have further enriched his research and contributed to the development of groundbreaking technologies in the field.
Conclusion
Juergen Distler's contributions to the field of cellular biology and his innovative patents are paving the way for advancements in the diagnosis and treatment of proliferative disorders. His work continues to impact the medical community positively, enhancing patient outcomes through improved diagnostic methods.